Short-term IIT can reduce post-challenge hyperglucagonemia in early T2DM, but this effect does not appear to be due to improved β-cell function.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: